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osting by EAbstract Zinc phosphide is a highly effective rodenticide used widely to protect grain in stores and
domestically to kill rodents. Acute poisoning may be direct by ingestion or indirect through acci-
dental inhalation of phosphine gas generated during its use. This study aims to identify the patterns
of intoxication with zinc phosphide among Egyptian patients admitted to the National Egyptian
Center of Clinical and Environmental Toxicological Research (NECTR); to study the role of anti-
ﬁbrinolytics in management of zinc phosphide toxicity; and to publish the results of the study,
which include recommendations for action towards planning prevention and education programs.
The study provides descriptive data and analysis of 188 cases admitted to the NECTR with acute
zinc phosphide poisoning over a period of 22 months. Results show that poisoning is more common
among females (60.6% of cases) than males (39.4%); the mean age is nearly 21 years old. The most
common cause of poisoning is suicidal attempts (83.6%) followed by accidental exposure (16.4%).
The most common causative factors that lead to self-poisoning are marital disharmony, economic
hardship, social problems and scolding from other family members. Signs and symptoms of toxicity
include gastrointestinal disturbances, respiratory compromise and changes in mental status. Other
features include disseminated intravascular coagulation, hepatic and renal impairment. Metabolic
disturbances had been reported. Death can result immediately due to pulmonary edema or delayed
due to cardiotoxicity. Patients must be admitted to hospital and observed for at least 3 days.
Symptomatic and supportive care is the mainstay of therapy. Zinc phosphide poisoning requires
gastric lavage with excessive sodium bicarbonate solution. Tranexamic acid – an antiﬁbrinolytic254011; fax: +20 2 23643129.
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150 A.M. El Naggar and N.M. El Mahdyagent – was found to be of help in some cases. Psychosocial counseling in cases of intentional poi-
soning is an important aspect of overall management of the problem.
ª 2011 Cairo University. Production and hosting by Elsevier B.V. All rights reserved.Introduction
It has been estimated that some form of poison directly or indi-
rectly is responsible for more than one million illnesses world-
wide annually. This ﬁgure could be just the tip of the iceberg
since most cases of poisoning actually go unreported, particu-
larly in Third World countries [1].
The problem of poisoning, both unintentional and inten-
tional, is getting worse with time as newer drugs and chemicals
are developing in huge numbers. Poisoning cases are increasing
day-by-day due to changes in lifestyle and social behavior.
Deliberate self-poisoning has reached epidemic proportions
in parts of the developing world [2]. Moreover, the problem
is not conﬁned to developing countries; it frequently occurs
in developed countries as well.
Pesticide poisoning from occupational, accidental and
intentional exposure is a major developing world public health
problem [3]. Millions of people are exposed to danger through
hazardous occupational practices and unsafe storage of pesti-
cides. Based on extrapolations from limited data, it was esti-
mated that three million cases of pesticide poisoning occur
world-wide annually with 220,000 deaths, the majority inten-
tional [4].
In Egypt in 1996 Abdelmegid and Salem surveyed 5913 pa-
tients admitted to the Alexandria Poison Center (APC) during
the previous year and recorded that pesticide poisoning ac-
counted for 14.3% of admitted cases [5]. In 2006, at Ain Shams
University, insecticide poisoning represented 51.0% of admit-
ted cases (a total of 21,805 cases); of this number, organophos-
phorus insecticides accounted for 75.0%, zinc phosphide
20.0% and carbamates 5.0% [6].
Zinc phosphide is a highly effective rodenticide. It is a crys-
talline, dark grey powder mixed into food as rodent bait. It is
also used widely to protect grain in stores and during
transportation.
Acute poisoning with this compound may be direct due to
ingestion of the salt or indirect from accidental inhalation of
phosphine gas (PH3) generated during its use [7].
Phosphides are normally found as powders or pellets, usu-
ally in the form of zinc or aluminum phosphide (Zn3P2 and
AlP, respectively); calcium and magnesium phosphides are also
available [8]. Due to its low price and easy availability, zinc
phosphide is emerging as a common self-poisoning agent in
Egypt.
Zinc phosphide ingested orally reacts with water and acid in
the stomach and produces phosphine gas, which may account
in large part for observed toxicity. Phosphine is an extremely
toxic gas, being highly irritating to the respiratory tract and
also producing severe systemic toxicity [9].
Phosphine acts by disrupting mitochondrial function
through blocking cytochrome C oxidase. In addition to pro-
ducing energy failure in cells, free radical generation increases,
resulting in lipid peroxidation [10,11]. Phosphine also inhibits
cholinesterases in rats [12].
Phosphides produce toxicity rapidly, generally within
30 min of ingestion; and death may follow in less than 6 h[13]. The ingestion of fresh unopened tablets consistently re-
sults in death [14]. Phosphide ingestions over 500 mg are often
fatal [15].
Phosphides are potent gastric irritants; profuse vomiting
and abdominal pain are often the ﬁrst symptoms [14]. Respira-
tory signs and symptoms include tachypnea, hyperpnea, dysp-
nea, cough and chest tightness that may progress to acute lung
injury over days [16–19]. Also, delayed onset non-cardiogenic
pulmonary edema can develop and once incurred it should
be managed aggressively using endotracheal intubation and
positive end-expiratory pressure (PEEP) ventilation [20].
Tachycardia, hypotension and dysrhythmias may develop.
Phosphine-induced dysrhythmias include atrial ﬁbrillation,
ﬂutter, heart block and ventricular tachycardia and ﬁbrillation
[21]. Other effects include central nervous system toxicity man-
ifested as coma, seizures, tonic-clonic convulsions and delirium
[13,18].
Hepatomegaly, raised transaminases, hepatic failure, severe
hypoglycemia or severe metabolic acidosis with acute distal re-
nal tubular acidosis, have been associated with zinc phosphide
ingestion [22,23]. Also acute pancreatitis has been reported
[7,24].
The aim of this study is to identify the patterns of intoxica-
tion with zinc phosphide among Egyptian patients admitted to
the National Egyptian Center of Clinical and Environmental
Toxicological Research (NECTR); to study the role of antiﬁb-
rinolytics in management of zinc phosphide toxicity; and to
publish the results of the study, which includes recommenda-
tions for action towards planning prevention and education
programs.Subjects and methodology
This retrospective study provides descriptive data and analysis
of 188 cases with a history of acute zinc phosphide poisoning
admitted to the NECTR over a period of 22 months (from
January 2007 to October 2008). Data of poisoning cases were
collected and analyzed with respect to age, sex, geographic dis-
tribution, causes of poisoning, clinical picture, management
procedures, outcome and length of hospital stay.Results
There were 188 cases with a history of acute poisoning with
zinc phosphide, of which 159 (84.5%) were zinc phosphide
alone; 6 cases (3%) involved food contaminated with zinc
phosphide; 19 cases (10%) involved zinc phosphide combined
with organophosphorus poisoning; and 4 cases (2%) involved
zinc phosphide combined with drugs. The last 23 cases were
analyzed separately to illustrate the clinical picture of com-
bined effects.
The amount of intentional ingested powder varies from 1/2
to two sachets (a sachet is 2–3 g).
Table 1 shows that the studied group comprised 100
females (60.6%) and 65 males (39.4%) and that age ranged
Table 1 Descriptive analysis of the studied group.
Sex Number % Age incidence
(in years)
Mean (in years) SD
Min Max
Males 65 39.4 1 55 21.9 ±8.8
Females 100 60.6 1.6 45 19.8 ±6.6
Total 165 100
Min =Minimum.
Max =Maximum.
Table 2 Age group distribution among a total number of 188
patients admitted to NECTR.
Age groups (in years) Number of patients %
0–9 9 4.8
10–19 85 45.2
20–29 79 42
30–39 9 4.8
>40 6 3.2
Graph 1 Geographic distribution.
Table 4 Analysis of recorded symptoms.
Initial presentation No. of
females
No. of
males
Total
number
%
Asymptomatic 30 10 40 24.2
Minor symptoms 38 22 60 36.4
Moderate symptoms 20 28 48 29.1
Major symptoms 12 5 17 10.3
Total 100 65 165 100
Asymptomatic = without any symptom or only dizziness.
Minor symptoms = in the form of GIT manifestations (epigastric
pain, nausea/or vomiting).
Moderate symptoms = included respiratory manifestations in
addition (dyspnea and excessive secretions).
Major symptoms = involved signs of other system affection
(tachycardia and hypotension, agitation, hallucinations and
depression).
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and from 1.6 to 45 years old in females with a mean of
19.8 years ± 6.6.
Table 2 shows that 45.2% of patients were 10–19 years old,
42% were 20–29 years old, 4.8% were less than 9 years old,
4.8% were 30–39 years old and 3.2% were more than 40 years
old.
Table 3 shows reasons for exposure, which were intentional
suicidal attempts in 83.6% of cases and accidental exposure in
16.4% of cases.
The geographic distribution shows that most cases were
from the Giza district (58.8%), then the Cairo district
(35.2%), then the other governorates including El-Fayoum,
El-Dakahleya, Assuit, Benisweif, El-Menia, El-Kalyoubeya
and El Behera at lower percentages up to 6% (Graph 1).
Table 4 shows the different clinical presentations of poi-
soned patients who were classiﬁed according to an internal
protocol applied in our centre as either asymptomatic or with
minor, moderate or major symptoms. Accordingly, 24.2% of
the patients were asymptomatic on arrival at the emergency
department, while 36.4%, 29.1% and 10.3%, presented with
minor, moderate and major symptoms, respectively.
Minor symptoms were in the form of GIT manifestations
(epigastric pain, nausea or vomiting); moderate symptoms in-
cluded respiratory manifestations in addition (dyspnea and
excessive secretions); and major symptoms involved signs of ef-Table 3 Causes of poisoning.
Sex Cause of poisoning
No. of suicide
attempts
% No. of accidental
poisoning
%
Males 54 83 11 17
Females 84 84 16 16
Total 138 83.6 27 16.4fects on other systems (tachycardia and hypotension, agita-
tion, hallucinations and depression).
Table 5 shows that 33.3% of cases were metabolically stable
on admission; 11.5% of cases presented with metabolic acido-
sis, of which 9.2% were in a compensated state; 10.3% pre-
sented with respiratory acidosis, of which 5.7% were in a
compensated state; 18.4% presented with respiratory alkalosis,
of which 10.3% were in a compensated state; 26.5% of cases
presented with mixed metabolic acidosis and respiratory alka-
losis, of which 19.6% were in a compensated state.
Table 6 shows that 30% of patients had elevated ALT lev-
els; 45% had elevated AST levels. Kidney function tests were
nearly within normal range; only 2.4% had an elevated urea
level. There were some electrolyte disturbances; 50% of pa-
tients had low sodium levels; 25% had low potassium levels.
Synthetic liver functions were performed in 1/3 of patients so
as to assess the condition of the liver and the need for treat-
ment with antiﬁbrinolytic or anticoagulation therapy. Results
revealed that 33% of them had prolonged PT, 10% had low
prothrombin concentration while INR and platelet count were
within normal range on admission.
The majority of cases (50%) presented to the emergency
department within 2 h of exposure; meanwhile 20% of cases
presented within 1 h, 10% after 4 h and the remaining 20%
within 6–12 h of exposure.
As regards management procedures, Table 7 shows that pa-
tients who presented within 2 h of exposure underwent gastric
lavage with sodium bicarbonate solution (61%); 32.7%
Table 5 Metabolic status of patients.
Metabolic status Number %
Normal 58 33.3
Metabolic acidosis (uncompensated) 4 2.3
Compensated metabolic acidosis 16 9.2
Respiratory acidosis (uncompensated) 8 4.6
Compensated respiratory acidosis 10 5.7
Respiratory alkalosis (uncompensated) 14 8.1
Compensated respiratory alkalosis 18 10.3
Mixed metabolic acidosis and respiratory alkalosis 12 6.9
Compensated mixed 34 19.6
Total 174 100
Differences recorded in the total number of cases were due to some
data missed in history taking.
Normal ABG values:
pH = 7.35–7.45.
PO2 = 95–100 mm Hg.
PCO2 = 35–45 mm Hg.
HCO3 = 24–28 mmol/L.
Diagnosis is based on the following criterion according to the
Henderson–Hasselbach parameters:
If the pH is within normal range but associated with respiratory or
metabolic disturbance, the patient is in a compensated state; if not
the case is uncompensated.
A respiratory disturbance alters the arterial PCO2, while metabolic
disturbance alters the HCO3:
Metabolic acidosis = pH value, PCO2 and HCO3 are below
normal ranges.
Metabolic alkalosis = pH and PCO2 and HCO3 are above
normal ranges.
Respiratory acidosis = pH is below normal range, HCO3 and
PCO2 are above normal ranges.
Respiratory alkalosis = pH is above normal range, HCO3 and
PCO2 are below normal ranges.
Mixed types = is diagnosed by Winter’s formula Expected
PCO2= (1.5 ·HCO3) + 8 ± 2.
This means that if a metabolic acidosis is present, we use Winter’s
formula to determine the respiratory response; in cases of simple
metabolic acidosis, the measured PCO2 will fall within the range
determined by the equation; if a respiratory disturbance is
coexisting, then PCO2 varies outside the range; if below the range,
a respiratory alkalosis is also occurring; if above the range, there is
respiratory acidosis.
N.B. The diagnosis did not depend upon measuring the anion gap,
as the studied cases were of ZP poisoning, so there was no need to
measure the anion gap as it would be essential only to differentiate
between the causes of metabolic acidosis.
Table 6 Analysis of different laboratory investigations.
Other investigations Patient values Normal values Number (%)
ALT >40 U/L Up to 40 30 (28.5)
AST >38 U/L Up to 38 45 (42.8)
Urea >50 mg/dL Up to 50 3 (2.4)
Creatinine >1.5 mg/dL Up to 1.5 0 (0)
Sodium <135 mmol/L 136–145 72 (50)
Potassium <3.5 mmol/L 3.5–5 36 (25)
Prothrombin time >12.3 s Control 12.3 55 (33)
Prothrombin
concentration
Out of range 80–100% 10 (6)
INR <1 1–1.2 0
Platelet count <150 150–450 0
Aspartate aminotransferase (AST) = up to 38 U/L.
Alanine aminotransferase (ALT) = up to 40 U/L.
Urea = 15–50 mg/dl.
Creatinine = 0.5–1.5 mg/dl.
Sodium (Na) = 136–145 mM/L.
Potassium (K) = 3.5–5.0 mM/L.
Prothrombin time (PT) = 12.3 s.
Prothrombin concentration (PC) = 80–100%.
International normalized ratio (INR) = 1.0–1.2.
Table 7 Analysis of management procedures.
Procedures Number of patients %
Gastric lavage with sodium
bicarbonate
100 61
Oral sodium bicarbonate 54 32.7
Activated charcoal 122 74
Others (ﬂuids, antispasmodic,
antiemetics, sedatives,
antibiotics, cathartics, etc.)
138 83.6
Tranexamic acid 16 9.7
Table 8 Analysis of medical outcome.
Medical outcome Number of patients %
Completely cured 59 35.7
Discharged with residual eﬀects 12 7.2
Discharged on consent 93 56.3
Death 1 0.6
Total 165 100
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was given to 74% of patients; other symptomatic treatment
used according to the condition of the patient included ﬂuid
administration, antispasmodics, antiemetics, sedatives, antibi-
otics and cathartics. Tranexamic acid as an antiﬁbrinolytic
agent was found to be of help in 9.7% of patients.
Table 8 shows the medical outcome of the studied cases:
complete cure was recorded in 35.7% of cases; 7.2% were dis-
charged with some residual effects such as mild abdominal
pain; 56.3% were discharged before 48 h on personal consent
for social or ﬁnancial reasons but most of these were com-
pletely cured as revealed on follow up in the outpatient clinic,
a percentage which should be added to the completely cured
ﬁgure; death was recorded only in 0.6% of cases due to delayin reaching the hospital, deterioration of the patient’s general
condition and development of pulmonary complications.
Depression was the commonest residual outcome in most cases
of intentional poisoning and these needed psychological assess-
ment and follow up with a specialist.
The length of hospital stay varied from 2 h to up to 2 days
with a mean of 13.36 h according to clinical condition and
other factors related to agony, social factors or economic
causes.
Patients who accidently ingested food contaminated with
zinc phosphide (3%) showed milder manifestations compared
with other cases; this could be explained by ingestion of a small
amount of poison, early presentation to the emergency depart-
ment and the performance of gastric lavage; there was one
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toxicity.
The patients who presented with suicidal ingestion of zinc
phosphide combined with carbamazepine overdose (1%) (20–
30 tablets), an enzyme inducer [25], exhibited a rapid appear-
ance of the toxic effects of poisoning with zinc phosphide in
the form of severe vomiting and epigastric pain; one of them
presented to the emergency unit within 1 h; the other presented
after 12 h with deterioration of his general condition in the
form of drowsiness, hypotension, hypokalemia, hallucinations
from the effects of carbamazepine overdose with metabolic aci-
dosis and pneumonic patches revealed on X-ray, and so
needed prolonged hospital stay and close monitoring.
A patient with suicidal ingestion of zinc phosphide com-
bined with alcohol, an enzyme inducing agent, presented with
severe metabolic acidosis, increased levels of liver enzymes,
hypokalemia and bradycardia, a picture that necessitates
aggressive therapy.
Patients who presented with suicidal ingestion of zinc phos-
phide combined with theophylline (1%) presented with their
combined effects on the GIT in the form of severe and re-
peated vomiting, which was not relieved by the usual antie-
metic drugs and so needed aggressive management; also,
metabolic acidosis was reported with tachycardia, hypotension
and hypokalemia, which necessitated intravenous ﬂuid and
electrolyte replacement and prolonged hospital stay compared
with other cases.
Ten percent of patients presented with ingestion of zinc
phosphide combined with organophosphorus compounds;
90% of them were suicide attempts and 10% were accidental
exposure. Most cases (80%) presented with severe vomiting
and abdominal pain in addition to muscle twitches and diar-
rhea, which indicated the combined effects of toxicity that re-
quired antidotal therapy (pralidoxime); 10% of cases needed
endotracheal intubation and artiﬁcial ventilation due to late
arrival, development of metabolic acidosis and deterioration
of the respiratory functions.Discussion
Acute poisoning with pesticides is a global public health prob-
lem. The easy availability of highly toxic pesticides in the
homes of farming communities has made pesticides the easiest
means of suicide with an extremely high case fatality. Simi-
larly, the extensive use of pesticides exposes the community
to both long-term and acute occupational health problems
[26].
In Egypt most farmers outside Cairo use phosphide tablets
extensively in grain stores, allowing the phosphine to be re-
leased once the storage sites are sealed. Phosphine exposure
and toxicity from phosphide salts occurs during grain fumiga-
tion in both transport and storage areas, causing inhalation of
the gas and reported cases of sudden death [13]; an important
event occurred in June 2009, when death was reported in nine
workers who were engaged in grain transportation in the Kal-
youbeya governorate; the condition was not discovered at the
time and caused a lot of controversy until diagnosed. Similarly,
an agricultural health study (AHS) cohort study performed in
Iowa and North Carolina (a cohort that included 52,629 pri-
vate applicators) revealed that 16% of workers who apply pes-
ticides in agriculture experienced a serious pesticide exposureevent. Fifty major type of pesticides were included, falling into
four main classes; herbicides, insecticides, fungicides and fum-
igants. The most frequent were alachlor, triﬂuralin, atrazine
and phorate [27].
Our study was limited to admissions to the NECTR that
represent only a small percentage of hospital admissions of
cases of zinc phosphide poisoning in Egypt; other cases would
present to other poison control centers such as the Ain Shams
hospital or general hospitals; in addition there are calls re-
ceived at the information unit and missed cases due to misdi-
agnosis or to ﬁnding difﬁculty in reaching any centre due to
scarcity of specialized centers in other governorates.
Unfortunately, it is not currently possible to link all the dat-
abases to provide a more comprehensive overview of poisoning
with zinc phosphide in our country; we think it is important
therefore to highlight our views on this type of poisoning
and to call for the publishing of statistical records of all cases
of poisoning in specialized and other general hospitals.
A total of 10,638 cases attended the NECTR during the
period of our study: 11.8% were pesticide poisoning and zinc
phosphide poisoning represented 15% of this percentage.
These results had not been previously published elsewhere
since our reference was the information unit of the NECTR.
The diagnosis is usually made from the history since phos-
phine tissue concentrations are not routinely available.
The results of this study show that oral ingestion was the
main route of poisoning, which is in agreement with other pub-
lications [28,29]. Most cases were teenagers and younger
adults, as in the majority of centers across the world, which
also record that the highest incidence of poisoning is in youn-
ger age groups [30–32] (Tables 1 and 2).
The differences recorded in geographical distribution might
be attributable to the easier access to the centre; the culture;
and to the magnitude of the problems encountered in over-
crowded rural areas, where easy access to toxic pesticides turns
many impulsive acts of self-poisoning into suicide.
The incidence of attempted suicide in females was greater
than in males (a ratio of 1.5:1) (Table 3), due to marital dishar-
mony, economic hardship, social problems and scolding from
other family members, which is in agreement with other studies
[30,33–35].
Due to their easy availability, pesticides have become the
most commonly used agent for suicide in the developing world
[36,37]. Since intentional self-poisoning is often impulsive and
simpliﬁed by easy availability of the poison, a proportion of
self-poisoning by pesticides can be prevented by reducing its
access. So regulating availability of pesticides and improving
medical management may reduce fatality from pesticide poi-
soning and also reduce the number of suicide attempts in
younger age groups [38].
Most patients in the study presented with abdominal pain
and vomiting (75.8%), followed by respiratory manifestations
(29.1%); systemic affection, which was evident in those who
did not seek medical help immediately or to their ingestion
of large amounts, presented to a lesser extent.
Initially asymptomatic patients (24.2%) attended the centre
because they feared death even though no symptoms had man-
ifested. Their actions were the result of a transient period of
distress, they did not have the actual desire to kill themselves;
they were only giving a cry for help to gain sympathy from
their relatives and help with their problems whether social or
economic.
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sion so they were put under observation in the intermediate
care unit (ICU). The rest (67%) required admission to the
intensive care unit (ICU) for adjustment and careful monitor-
ing; 11.5% of them presented with metabolic acidosis, which is
in agreement with other studies [23,39–41]; 26.5% presented
with mixed metabolic acidosis and respiratory alkalosis in
accordance with other studies [39,42] (Table 5); patients with
severe respiratory compromise (20%) required intubation
and artiﬁcial ventilation.
With regard to systemic toxicity encountered with phos-
phine, it has been proved that the major targets of PH3 poison-
ing in the human body are the lungs, heart, brain,
gastrointestinal tract, kidney and liver [43,44], in our study,
30% of patients showed elevated ALT levels, 45% had ele-
vated AST levels without history of previous liver affection,
which reﬂected the hepatotoxicity [7,42]. Saleki et al. in 2007
[45] stated that PH3 can cause liver dysfunction, especially
after the ﬁrst day of poisoning, and that the main histopatho-
logic changes found were ﬁne cytoplasmic vacuolization of
hepatocytes and sinusoidal congestion. Similar condition was
recorded in the case presentation of Khurana et al. in 2009
[46] who found elevated transaminases levels; also Karanth
and Nayyar in 2003 [47] recorded severe hepatic dysfunction
in their cases. Congestion, oedema and centrizonal necrosis
of the liver were found on histopathological examination in
the study of Musshoff et al. in 2008 [48].
No kidney affection was recorded in our study; kidney
function tests were nearly within normal range; only 2.4%
had an elevated urea level.
There were some electrolytes disturbances; 50% of patients
had hyponatremia, similar to the case study of Khurana et al.
in 2009 [46]; it is caused most probably by excessive vomiting
and diarrhea or may be related to adrenal insufﬁciency.
Twenty-ﬁve percent suffered hypokalemia, which may be re-
lated to repeated vomiting; Proudfoot [39] also attributed its
occurrence to catecholamine release.
Zinc phosphide poisoned patients were carefully evaluated
with complete history and physical examination. Symptomatic
and supportive care was the mainstay of therapy. Some toxi-
cology references suggest induction of emesis within 30 min
post ingestion [41]. Gastric lavage with water or 3–5% sodium
bicarbonate (to reduce gastric acid and production of phos-
phine) [39], or 1:5000 potassium permanganate (to oxidize
phosphine to less absorbable phosphide) has been advised;
however, other researchers stated that its effectiveness is un-
proven [49]. Each of these decontamination techniques carries
its own risks and physicians must be aware of these dangers be-
fore undertaking any decontamination measures, taking into
consideration the importance of airway protection.
Gastrointestinal decontamination with administration of
sodium bicarbonate solution was performed in nearly 61%
of our patients who presented within 4 h of poisoning; they
showed better outcome than cases who presented later and
who did not receive gastric lavage (Table 6).
Those who came late (32.7%) received oral sodium bicar-
bonate solution in a trial to oxidize any remnants in the gastro-
intestinal tract; activated charcoal as adsorbent was given in
74% of patients; other symptomatic treatments were used
according to the condition of the patient as follows: ﬂuid
administration, antispasmodics, antiemetics, sedatives, antibi-
otics and cathartics (Table 7).During the observation period, patients were closely moni-
tored for cardiac affection by ECG monitoring, with assess-
ment of hepatic and renal functions as well as ﬂuid and
electrolyte status.
Death was recorded in one case only who presented after
24 h of poisoning with bad general condition; he received basic
therapy but unexpectedly developed sudden repeated hemopt-
ysis suggesting the development of a hemorrhagic diathesis;
intubation and artiﬁcial ventilation was performed but the pa-
tient’s condition deteriorated rapidly and before receiving any
corrective therapy he developed respiratory failure and died.
This case raised our attention to the possibility of the devel-
opment of disseminated intravascular coagulopathy (DIC) as
recorded in previous studies [39,42,46,50–52]. Proudfoot in
2009 [39] attributed its occurrence to the highly toxic phos-
phine gas not to the metal phosphides. Sood et al. in 1997
[50] stated that metabolic acidosis accompanying aluminium
phosphide poisoning could have been responsible for the acute
hemolytic episode recorded in their patient; a picture similar to
that observed in our patient. Srinivas et al. in 2007 [51] de-
scribed a patient with ALP poisoning presenting with intravas-
cular hemolysis secondary to G6PD deﬁciency. However,
Aggarwal et al. in 1999 [42] had proved the occurrence of
intravascular hemolysis with aluminium phosphide poisoning
in a patient with normal G-6-PD levels. Khurana et al. in
2009 [46] proved in addition the occurrence of microangio-
pathic hemolytic anemia (MAHA) in a patient who ingested
aluminum phosphide. They stated that aluminum phosphide,
being a redox substance, can theoretically cause hemolytic ane-
mia. Aluminum phosphide could be associated with DIC,
which is a well-recognized cause of MAHA. From this re-
search, we can justify the possibility of the occurrence of
DIC in phosphide poisoning.
Some patients presented with the usual picture of zinc phos-
phide poisoning (profuse vomiting, abdominal pain); then the
condition deteriorated rapidly, from drowsiness, pallor, rest-
lessness, irritability, tachycardia, hypotension, bleeding from
gums or at the site of injection, to a disturbed conscious level,
and shock and respiratory distress in some patients. Close clin-
ical monitoring was done with full investigations that revealed
the development of metabolic disturbances, elevated transam-
inases, low hemoglobin levels, prolonged prothrombin times
and thrombocytopenia in most of them. Although not rou-
tinely used in management, but owing to the development of
DIC, we began our trial using tranexamic acid, an antiﬁbrino-
lytic agent, which competitively inhibits the activation of plas-
minogen to plasmin, a molecule responsible for the
degradation of ﬁbrin, which is the basic framework for the for-
mation of a blood clot in hemostasis [53]. Tranexamic acid was
started by a loading dose of 10 mg/kg intravenously followed
by a maintenance dose of 10 mg/kg three times daily for 2–
8 days according to the condition; two cases needed blood
transfusion in addition due to low hemoglobin level; 2 days la-
ter, with continuous supportive care, patients showed a grad-
ual improvement in their general condition with progressive
improvement in liver function tests, coagulation proﬁle and
platelet count. Complete cure occurred within 1–2 weeks in
all cases.
The use of steroids in the management of such patients was
also greatly recommended for several reasons including stress-
ful situations and hypotension [54,55], to minimize the possi-
bility of pulmonary injury [54,56], as well as of
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orrhage in the adrenal cortex as recorded in the study of
Chugh et al. in 1989 [57] who detected severe adreno-cortical
involvement in some patients; histopathological examination
revealed severe changes in the adrenal cortex (complete lipid
depletion, hemorrhage, necrosis, etc.) and all these patients
died. They attributed these changes to shock or to the cellular
toxic effect of phosphine, a ﬁnding also recorded by Arora
et al. in 1995 [58] where histopathological changes were ob-
served in various body organs such as lungs, liver, kidneys,
heart, brain, stomach and adrenals, including varying degrees
of congestion, edema and leucocytic inﬁltration changes sug-
gestive of cellular hypoxia. Even adrenal gland damage can oc-
cur, as recorded by Proudfoot in 2009 [39].
Recommendations
Our recommendations focus on the importance of providing
awareness to medical and paramedical staff of the manifesta-
tions of zinc phosphide poisoning especially in rural areas, to
improve case management and to raise public awareness so
as to limit the unregulated sale of this toxic compound.
Collaboration between different poison control centers for
data-gathering about cases of zinc phosphide and other pesti-
cide poisonings will help to create a solid database and a full
picture of the actual condition in our country and will subse-
quently assist us to assess the magnitude of the problem and
to perform the required actions.
Further research including studies on a larger scale should
be considered concerning the use of antiﬁbrinolytics and ste-
roids in the management of poisoned patients, to improve their
prognosis.
Another important issue is psychosocial counseling, which
is an important aspect of the overall management of the prob-
lem of attempted suicide.
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